These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23636170)

  • 41. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1662-8. PubMed ID: 20036201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression.
    Meijers BK; Evenepoel P
    Nephrol Dial Transplant; 2011 Mar; 26(3):759-61. PubMed ID: 21343587
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
    Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
    Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
    Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
    Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
    Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
    Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
    Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
    Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uremic Toxin Clearance and Cardiovascular Toxicities.
    Mair RD; Sirich TL; Meyer TW
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients.
    Lu YC; Wu CC; Tsai IT; Hung WC; Lee TL; Hsuan CF; Yu TH; Wei CT; Chung FM; Lee YJ; Wang CP
    Clin Chim Acta; 2021 May; 516():83-91. PubMed ID: 33508250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.
    Assis RP; Castro JF; Gutierres VO; Arcaro CA; Brotto RS; Oliveira OM; Baviera AM; Brunetti IL
    BMC Nephrol; 2015 Apr; 16():50. PubMed ID: 25886160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a LC-MS/MS method for quantitative analysis of uraemic toxins p-cresol sulphate and indoxyl sulphate in saliva.
    Giebułtowicz J; Korytowska N; Sankowski B; Wroczyński P
    Talanta; 2016 Apr; 150():593-8. PubMed ID: 26838447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.
    Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L;
    J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unambiguous Characterization of
    Paroni R; Casati S; Dei Cas M; Bignotto M; Rubino FM; Ciuffreda P
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31618977
    [No Abstract]   [Full Text] [Related]  

  • 59. Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis.
    Sirich TL; Aronov PA; Fullman J; Nguyen K; Plummer NS; Meyer TW
    PLoS One; 2017; 12(11):e0188315. PubMed ID: 29145509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW;
    Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.